Use of heparin-coated "Jo Stent M" in patients with ischemic heart disease: first results

The aim of the present study was to make a clinical and angiographic assessment of early outcomes of the use of heparin-coated new "Jo Stents M". The Study comprised 41 patients who were implanted a heparin-coated new "Jo Stent M". There was an immediate success in 45 (97.6%) of 46 cases, the optimal angiographic and suboptimal (the maximum residual stenosis (13%)) results being achieved in 43 (93.4%) and 2 (4.4%) cases, respectively. The first success of the procedure was 97.8%. Due to acute stent thrombosis, acute occlusion with evolving myocardial infarction occurred in 1 (2.4%) patient. Following the procedure, the mean proportion of the stenotic diameter was (-5.8 +/- 6)%. After the procedure, the minimum stenotic diameter with the mean due diameter of 2.9 +/- 0.5 mm was 3.0 +/- 0.2 mm. The procedure-induced diameter increase was 2.1 +/- 0.5 mm. The total number of lateral branches involved in the stenting area was 11 (100%), 2 (18.2) of them closed after stent implantation. Two branches came into the stenting area in 1 (2.4%) case. At discharge, angina pectoris was absent in 30 (74%) patients. The heparin-coated "Jo Stent M" are effective and safe in treating patients with various clinical and angiographic manifestations of coronary atherosclerotic lesions.